A phase I trial of rituximab and interleukin-2
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Interleukin-2 (Primary) ; Rituximab (Primary) ; Aldesleukin
- Indications B-cell lymphoma; Precursor cell lymphoblastic leukaemia-lymphoma
- Focus Adverse reactions; Pharmacokinetics
- 06 Jun 2013 Biomarkers information updated
- 06 Oct 2005 New trial record.